Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_assertion type Assertion NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_head.
- NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_assertion description "[KRAS mutations constitutively activate the RAS/RAF/mitogen-activated protein kinase (MAPK) pathway and therefore play an important role in anti-epidermal growth factor receptor therapy for patients with colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_provenance.
- NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_assertion evidence source_evidence_literature NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_provenance.
- NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_assertion SIO_000772 22938585 NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_provenance.
- NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_assertion wasDerivedFrom befree-20140225 NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_provenance.
- NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_assertion wasGeneratedBy ECO_0000203 NP650196.RAuMlRmf-dtjK1RJfc2NZHu-VlQmHgpkPAKSILrnGLBPc130_provenance.